10x Genomics, Inc. (NASDAQ:TXG) Receives $15.81 Consensus Price Target from Brokerages
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received an average rating of “Hold” from the sixteen brokerages that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and seven have issued a buy recommendation on the company. The […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) has received an average rating of “Hold” from the sixteen brokerages that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and seven have issued a buy recommendation on the company. The […]
